Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report

BACKGROUND: Pain is the highest prioritized patient-reported outcome in people with autosomal dominant polycystic kidney disease (ADPKD) but remains infrequently and inconsistently measured in clinical trials and poorly managed in clinical settings. A recently completed systematic review of pain in...

Descripción completa

Detalles Bibliográficos
Autores principales: Natale, Patrizia, Perrone, Ronald D, Tong, Allison, Harris, Tess, Hannan, Elyssa, Ju, Angela, Burnette, Eva, Casteleijn, Niek F, Chapman, Arlene, Eastty, Sarah, Gansevoort, Ron T, Hogan, Marie, Horie, Shigeo, Knebelmann, Bertrand, Lee, Richard, Mustafa, Reem A, Sandford, Richard, Baumgart, Amanda, Craig, Jonathan C, Rangan, Gopala K, Sautenet, Bénédicte, Viecelli, Andrea K, Amir, Noa, Evangelidis, Nicole, Guha, Chandana, Logeman, Charlotte, Manera, Karine, Matus Gonzalez, Andrea, Howell, Martin, Strippoli, Giovanni F M, Cho, Yeoungjee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862067/
https://www.ncbi.nlm.nih.gov/pubmed/35211300
http://dx.doi.org/10.1093/ckj/sfab110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862067/
https://www.ncbi.nlm.nih.gov/pubmed/35211300
http://dx.doi.org/10.1093/ckj/sfab110

Ejemplares similares